Antheia is a pharmaceutical ingredient manufacturer focused on transforming essential medicine supply chains through its advanced biomanufacturing platform. The company is committed to commercializing a diverse pipeline of over 70 biosynthetic pharmaceutical ingredients across seven therapeutic areas, prioritizing essential medicines that are in or at risk of shortage. Antheia aims to enhance domestic manufacturing capabilities and expand its strategic innovation programs into Asia.
Leadership & Board
Current Number of Employees70
Current LinkedIn Followers10,123
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$80M
Total Amount Raised$80M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$24M
Latest Funding Amount$24M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Antheia had 70 employees as of September 14, 2026. The number of employees increased by 1 (1.45%) week-over-week.
70Latest Employee Count
1(1.45%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Antheia had 10,123 followers as of September 14, 2026. The number of followers increased by 15 (0.15%) week-over-week.
10,123Latest Followers Count
15(0.15%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.